NCT05934149 Lupus Landmark Study: A Prospective Registry and Biorepository
| NCT ID | NCT05934149 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lupus Research Alliance |
| Condition | Systemic Lupus Erythematosus (SLE) |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,500 participants |
| Start Date | 2023-06-28 |
| Primary Completion | 2035-12 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).
Eligibility Criteria
Inclusion Criteria: * Able to understand and comply with study procedures and voluntarily sign a written informed consent document * Age 18 years or older at the time of enrollment * Fulfill criteria for SLE based on one or more of the following classifications systems: Systemic Lupus Erythematosus International Collaborating Clinic (SLICC) 2012 criteria; European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 criteria; 1997 revised ACR criteria; or Lupus is present per clinical assessment. Exclusion Criteria: * Not able to obtain consent * Not able to meet protocol visit requirements * Pregnant at the time of enrollment
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.